- Home
- PNRG vs FENC Comparison
PNRG vs FENC Comparison
Compare PNRG & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNRG | FENC |
|---|---|---|
| Founded | 1973 | 1996 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.1M | 263.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PNRG | FENC |
|---|---|---|
| Price | $169.00 | $8.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 54.3K | ★ 103.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.78 |
| P/E Ratio | $16.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $126.40 | $4.68 |
| 52 Week High | $238.20 | $9.92 |
Technical Indicators
Market Signals| Indicator | PNRG | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 70.74 |
| Support Level | $184.55 | $7.56 |
| Resistance Level | $199.85 | $8.66 |
| Average True Range (ATR) | 9.76 | 0.38 |
| MACD | -1.90 | 0.10 |
| Stochastic Oscillator | 0.48 | 87.19 |
Price Performance
Historical ComparisonAbout PNRG PrimeEnergy Resources Corporation
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.